These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
229 related articles for article (PubMed ID: 32952669)
1. Engineered targeting tLyp-1 exosomes as gene therapy vectors for efficient delivery of siRNA into lung cancer cells. Bai J; Duan J; Liu R; Du Y; Luo Q; Cui Y; Su Z; Xu J; Xie Y; Lu W Asian J Pharm Sci; 2020 Jul; 15(4):461-471. PubMed ID: 32952669 [TBL] [Abstract][Full Text] [Related]
2. Engineered Exosomes for Targeted Transfer of siRNA to HER2 Positive Breast Cancer Cells. Limoni SK; Moghadam MF; Moazzeni SM; Gomari H; Salimi F Appl Biochem Biotechnol; 2019 Jan; 187(1):352-364. PubMed ID: 29951961 [TBL] [Abstract][Full Text] [Related]
3. Peptide-Targeted High-Density Lipoprotein Nanoparticles for Combinatorial Treatment against Metastatic Breast Cancer. Jiang C; Wang X; Teng B; Wang Z; Li F; Zhao Y; Guo Y; Zeng Q ACS Appl Mater Interfaces; 2021 Aug; 13(30):35248-35265. PubMed ID: 34284582 [TBL] [Abstract][Full Text] [Related]
4. Exosomes of Mesenchymal Stem Cells as a Proper Vehicle for Transfecting miR-145 into the Breast Cancer Cell Line and Its Effect on Metastasis. Sheykhhasan M; Kalhor N; Sheikholeslami A; Dolati M; Amini E; Fazaeli H Biomed Res Int; 2021; 2021():5516078. PubMed ID: 34307654 [TBL] [Abstract][Full Text] [Related]
5. Stabilization of exosome-targeting peptides via engineered glycosylation. Hung ME; Leonard JN J Biol Chem; 2015 Mar; 290(13):8166-72. PubMed ID: 25657008 [TBL] [Abstract][Full Text] [Related]
6. iRGD-modified exosomes-delivered BCL6 siRNA inhibit the progression of diffuse large B-cell lymphoma. Liu Q; Dai G; Wu Y; Zhang M; Yang M; Wang X; Song M; Li X; Xia R; Wu Z Front Oncol; 2022; 12():822805. PubMed ID: 35982974 [TBL] [Abstract][Full Text] [Related]
7. Engineering blood exosomes for tumor-targeting efficient gene/chemo combination therapy. Zhan Q; Yi K; Qi H; Li S; Li X; Wang Q; Wang Y; Liu C; Qiu M; Yuan X; Zhao J; Hou X; Kang C Theranostics; 2020; 10(17):7889-7905. PubMed ID: 32685027 [No Abstract] [Full Text] [Related]
8. Cell-free synthesis of connexin 43-integrated exosome-mimetic nanoparticles for siRNA delivery. Lu M; Zhao X; Xing H; Liu H; Lang L; Yang T; Xun Z; Wang D; Ding P Acta Biomater; 2019 Sep; 96():517-536. PubMed ID: 31284098 [TBL] [Abstract][Full Text] [Related]
9. Engineered Exosomes With Ischemic Myocardium-Targeting Peptide for Targeted Therapy in Myocardial Infarction. Wang X; Chen Y; Zhao Z; Meng Q; Yu Y; Sun J; Yang Z; Chen Y; Li J; Ma T; Liu H; Li Z; Yang J; Shen Z J Am Heart Assoc; 2018 Aug; 7(15):e008737. PubMed ID: 30371236 [TBL] [Abstract][Full Text] [Related]
10. A doxorubicin delivery platform using engineered natural membrane vesicle exosomes for targeted tumor therapy. Tian Y; Li S; Song J; Ji T; Zhu M; Anderson GJ; Wei J; Nie G Biomaterials; 2014 Feb; 35(7):2383-90. PubMed ID: 24345736 [TBL] [Abstract][Full Text] [Related]
11. tLyP-1-conjugated Au-nanorod@SiO(2) core-shell nanoparticles for tumor-targeted drug delivery and photothermal therapy. Xu B; Ju Y; Cui Y; Song G; Iwase Y; Hosoi A; Morita Y Langmuir; 2014 Jul; 30(26):7789-97. PubMed ID: 24921672 [TBL] [Abstract][Full Text] [Related]
12. Delivery of High Mobility Group Box-1 siRNA Using Brain-Targeting Exosomes for Ischemic Stroke Therapy. Kim M; Kim G; Hwang DW; Lee M J Biomed Nanotechnol; 2019 Dec; 15(12):2401-2412. PubMed ID: 31748020 [TBL] [Abstract][Full Text] [Related]
13. Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes. Alvarez-Erviti L; Seow Y; Yin H; Betts C; Lakhal S; Wood MJ Nat Biotechnol; 2011 Apr; 29(4):341-5. PubMed ID: 21423189 [TBL] [Abstract][Full Text] [Related]
14. The Evaluation of tLyP-1-Bound Rastegari M; Shiri A; Behzad-Behbahani A; Rasoolian M; Zare F; Rafiei G; Mortazavi M; Sharifzadeh S; Hosseini SY Cancer Biother Radiopharm; 2021 Dec; 36(10):827-836. PubMed ID: 32493109 [No Abstract] [Full Text] [Related]
15. Fusion protein engineered exosomes for targeted degradation of specific RNAs in lysosomes: a proof-of-concept study. Li Z; Zhou X; Gao X; Bai D; Dong Y; Sun W; Zhao L; Wei M; Yang X; Yang G; Yuan L J Extracell Vesicles; 2020 Sep; 9(1):1816710. PubMed ID: 33133429 [TBL] [Abstract][Full Text] [Related]
16. Exosome as a Natural Gene Delivery Vector for Cancer Treatment. Pofali P; Mondal A; Londhe V Curr Cancer Drug Targets; 2020; 20(11):821-830. PubMed ID: 32972340 [TBL] [Abstract][Full Text] [Related]
17. Exosome-Modified Tissue Engineered Blood Vessel for Endothelial Progenitor Cell Capture and Targeted siRNA Delivery. Chen W; Yang M; Bai J; Li X; Kong X; Gao Y; Bi L; Xiao L; Shi B Macromol Biosci; 2018 Feb; 18(2):. PubMed ID: 29205878 [TBL] [Abstract][Full Text] [Related]
18. Targeted Delivery of Exosomes Armed with Anti-Cancer Therapeutics. Choi H; Yim H; Park C; Ahn SH; Ahn Y; Lee A; Yang H; Choi C Membranes (Basel); 2022 Jan; 12(1):. PubMed ID: 35054611 [TBL] [Abstract][Full Text] [Related]
19. [The transfection of lentiviral siRNA vectors targeting ezrin, radixin and moesin facilitates influenza virus replication in primary pulmonary microvascular endothelial cells]. Wu Y; Zhang S; Zhang C; Xuan Z; Li S; Gao Y; Hu Y Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2015 Apr; 31(4):456-61. PubMed ID: 25854562 [TBL] [Abstract][Full Text] [Related]
20. Systemic Delivery of NAC-1 siRNA by Neuropilin-Targeted Polymersomes Sensitizes Antiangiogenic Therapy of Metastatic Triple-Negative Breast Cancer. Wang H; Wang X; Zhang Y; Cheng R; Yuan J; Zhong Z Biomacromolecules; 2020 Dec; 21(12):5119-5127. PubMed ID: 33174734 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]